Heart Failure Flashcards

1
Q

Define HF. (1)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the cardinal symptoms of HF? (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the cardinal signs of HF? (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the resulting effects of HF? (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give e.g. of conditions that damage heart muscle or limit its ability to function normally. (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give e.g. of conditions that reduce cardiac output. (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give e.g. of conditions that result in a high cardiac output. (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the main features of left HF? (5)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the main features of right HF? (5)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 main classifications of HF? (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 3 subtypes of LVEF? (3)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the Class 1 features of NYHA Classification? (1)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the Class 2 features of NYHA Classification? (1)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Class 3 features of NYHA Classification? (1)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Class 4 features of NYHA Classification? (1)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the main characteristics of RAAS? (5)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the expected aldosterone level in HF? (1)

A

20 x normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Explain the effect of decrease in CO. (1)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the initial benefit of SNS? (4)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the eventual harm of SNS? (4)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the s/s of HF? (15)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the common presentations of HF in hospitals? (7)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the common presentations of HF in community? (1)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Outline the diagnostic process of chronic HF.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the potential complications of HF? (5)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Outline the management of chronic HF.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is decompensated HF? (1)

28
Q

What is the inpatient management of decompensated HF? (8)

29
Q

When would diuretics be used in HF? (5)

30
Q

What are the cautions of Diuretics in HF? (2)

31
Q

What are the monitoring requirements of Diuretics for HF? (2)

32
Q

Give e.g. of loop diuretics used for HF. (4)

33
Q

Give e.g. of thiazide-like diuretics used for HF. (2)

34
Q

What does NICE guidelines state about pharmacological therapy in HF? (2)

35
Q

Outline the pharmacological therapies available for HFrEF. (6)

36
Q

When would ACEI be used as HF tx? (4)

37
Q

What aims the monitoring requirement for ACEi? (1)

38
Q

How often should the dose of ACEi be adjusted? (2)

39
Q

When would Sacubitril/Valsartan be used as HF tx? (5)

40
Q

What are the dosing regimens for Sacubutril/valsartan? (2)

41
Q

When would it NOT be appropriate to start Sacubitril/Valsartan? (1)

42
Q

Explain the main features of MRA (Aldosteorne Antagonists) (5)

43
Q

What is Spironolactone? (1)

44
Q

When is spironolactone used as for HF tx? (1)

45
Q

What is the usual dose for Spironolactone? (2)

46
Q

What are the monitoring requirements for Spironolactone? (1)

47
Q

What are the major problems with Spironolactone? (3)

48
Q

What is Eplerenone? (2)

49
Q

Explain the benefit of selectivity of Eplerenone. (2)

50
Q

What is the indication of Eplerenone? (1)

51
Q

What are the usual dosing regimens for Eplerenone? (2)

52
Q

What are the common s/e of Eplerenone? (4)

53
Q

What is a common interaction with Eplerenone? (1)

54
Q

Give e.g. of SGLT2i used in HF. (2)

55
Q

What is the licensed use of SGLT2i? (1)

56
Q

What is the dosing regimen of SGLT2i in HF? (1)

57
Q

What condition should you not use SGLT2i for HF tx? (1)

58
Q

What counselling point is given to patients taking SGLT2i? (3)

59
Q

What is the licensed use of Digoxin? (3)

60
Q

What are the monitoring requirements of Digoxin? (3)

61
Q

State the licensed use of Ivabradine. (3)

62
Q

When would Ivabradine be used as HF treatment? (2)

63
Q

What are the monitoring requirements of ACEi, BB + MRA? (3)

64
Q

Give e.g. of medicines that may affect heart failure. (4)

65
Q

Give e.g. of comorbidities that should be managed in HF. (7)